Home >>Botany >> Eucommia ulmoides

Eucommia ulmoides

Eucommia ulmoides

1. The products in our compound library are selected from thousands of unique natural products; 2. It has the characteristics of diverse structure, diverse sources and wide coverage of activities; 3. Provide information on the activity of products from major journals, patents and research reports around the world, providing theoretical direction and research basis for further research and screening; 4. Free combination according to the type, source, target and disease of natural product; 5. The compound powder is placed in a covered tube and then discharged into a 10 x 10 cryostat; 6. Transport in ice pack or dry ice pack. Please store it at -20 °C as soon as possible after receiving the product, and use it as soon as possible after opening.

Natural products/compounds from  Eucommia ulmoides

  1. Cat.No. Product Name CAS Number COA
  2. BCN6049 Quercetin117-39-5 Instructions
  3. BCN6231 Asperuloside14259-45-1 Instructions
  4. BCN6232 Daphylloside14260-99-2 Instructions
  5. BCN1684 Rutin153-18-4 Instructions
  6. BCN1688 Catechin154-23-4 Instructions
  7. BCN1153 Loganin18524-94-2 Instructions
  8. BCN2771 Quercetin-3-O-sophoroside18609-17-1 Instructions
  9. BCN5104 Geniposide24512-63-8 Instructions
  10. BCN3088 Asperulosidic acid25368-11-0 Instructions
  11. BCN5171 Geniposidic acid27741-01-1 Instructions
  12. BCN6315 Procyanidin B229106-49-8 Instructions
  13. BCN5906 Chlorogenic acid327-97-9 Instructions
  14. BCN6432 D-(+)-Fucose3615-37-0 Instructions
  15. BCN5503 Corosolic acid4547-24-4 Instructions
  16. BCN8319 alpha-Linolenic acid463-40-1 Instructions
  17. BCN5528 Betulin473-98-3 Instructions
  18. BCN5355 Aucubin479-98-1 Instructions
  19. BCN5549 Astragalin480-10-4 Instructions
  20. BCN5569 Isoquercitrin482-35-9 Instructions
  21. BCN5597 Epicatechin490-46-0 Instructions
  22. BCN0310 trans-p-Coumaric acid501-98-4 Instructions
  23. BCN1247 Isorhamnetin-3-O-beta-D-Glucoside5041-82-7 Instructions
  24. BCN5665 Quercitrin522-12-3 Instructions
  25. BCN5771 Avicularin572-30-5 Instructions
  26. BCN1022 Schizandrin B61281-37-6 Instructions
  27. BCN1093 Pinoresinol diglucoside63902-38-5 Instructions
  28. BCN2600 Syringaresinol-di-O-glucoside66791-77-3 Instructions
  29. BCN5932 Genipin6902-77-8 Instructions
  30. BCN1376 Pinoresinol 4-O-beta-D-glucopyranoside69251-96-3 Instructions
  31. BCN4327 Ursolic acid77-52-1 Instructions
  32. BCN2563 4-Methylumbelliferone90-33-5 Instructions

References

Antioxidant and xanthine oxidase inhibitory activity of Eucommia ulmoides Oliver leaf extracts.[Pubmed: 30033417]


None


Two pairs of phenylpropanoid enantiomers from the leaves of Eucommia ulmoides.[Pubmed: 29996684]


None


Aucubin alleviates glial cell activation and preserves dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian mice.[Pubmed: 29985188]


Aucubin (AUC) is a major bioactive ingredient in Eucommia ulmoides, Plantain asiatica, and Aucuba japonica, and has been shown to exert anti-inflammatory, antioxidative, and neuroprotective effects. We explore the neuroprotective effects of AUC in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonian mice. Mice were administered MPTP (30 mg/kg) daily for 5 days, followed by treatment with AUC for 7 days. Measurement of dopamine levels was performed by high-performance liquid chromatography and tyrosine hydroxylase expression was assessed by western blot. Our results showed that AUC treatment improved mobility in the pole descent test and the traction test, and reduced the loss of dopaminergic neurons in MPTP-induced parkinsonian mice. AUC treatment rescued the decreased dopamine and tyrosine hydroxylase levels in the striatum of parkinsonian mice. Furthermore, AUC treatment reduced both microglia and astrocyte activation in the substantia nigra of parkinsonian mice. These findings suggest that AUC exerts neuroprotective effects, in part by reducing inflammation and preserving dopaminergic neurons. Possible protection mechanisms involved in MPTP-induced parkinsonian mice need to be clarified further.